Pharmacotherapy for Obesity
نویسندگان
چکیده
BACKGROUND Obesity is a serious, chronic, relapsing disease of energy regulation, with strong genetic and early-life environmental determinants. Pharmacotherapy can be a useful adjunct to lifestyle intervention in effecting and maintaining clinically meaningful weight loss. OBJECTIVE The aim of this article is to discuss the role of pharmacotherapy in obesity management. The efficacy, side effects and contraindications of available weight-loss medications are reviewed. DISCUSSION Long-term pharmacotherapy options, which can be effective in providing moderate weight loss, are available to treat obesity. Pharma-cotherapy should be considered an adjunct to lifestyle intervention in those with a body mass index (BMI) >30 kg/m30 kg/m2, or in those with a BMI of 27-30 kg/m2 and obesity-related complications. Safety and efficacy should be monitored closely on commencement, and the medication should be discontinued if there are safety or tolerability issues, or if.
منابع مشابه
Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals
INTRODUCTION Rates of obesity pharmacotherapy use, bariatric surgery and intensive behavioural counselling have been extremely low. OBJECTIVES The primary objective of this study was to survey healthcare provider beliefs, practice and knowledge regarding obesity management. METHODS Primary care physicians (PCPs), OB-GYN physicians and nurse practitioners (NPs) responded to a web-based surve...
متن کاملThe Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
Obesity has become a serious public health problem that has stimulated primordial and primary prevention efforts, and a triad of management options (lifestyle, pharmacotherapy, and surgical interventions). A growing body of evidence supports the need for a multi-pronged, clinic-based approach that leverages the synergy between pharmaceutical and lifestyle modification. Recent US policy changes-...
متن کاملObesity in Korean Men: Results from the Fourth through Sixth Korean National Health and Nutrition Examination Surveys (2007~2014)
PURPOSE Obesity is related to many diseases, including urological conditions. We investigated the prevalence, risk factors, and treatment of male obesity. MATERIALS AND METHODS This study included 17,485 men older than 20 years of age who participated in the fourth, fifth, and sixth administrations of the Korean National Health and Nutrition Examination Survey. Two main cutoff points for obes...
متن کاملManagement of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
The US Food and Drug Administration (FDA) recently approved lorcaserin and the combination of phentermine and extended release topiramate (phentermine/topiramate ER) for the treatment of obesity in conjunction with a lifestyle intervention, expanding the therapeutic options for long-term obesity pharmacotherapy, which was previously limited to orlistat. Combination phentermine/topiramate ER is ...
متن کاملCardiovascular side effects of antiobesity drugs: a yellow flag in the race to safe pharmacotherapy for obesity.
The global surge in obesity with its attendant increase in diabetes mellitus, dyslipidemia, hypertension, and cardiovascular disease is provoking alarm. Fortunately, the surge in obesity has been paralleled by a revolution in understanding the biological regulation of appetite, metabolism, and adiposity.1,2 Mushrooming discoveries are identifying new pathways regulating appetite and metabolism....
متن کاملQuantifying Energy Intake Changes during Obesity Pharmacotherapy
OBJECTIVE Despite the fact that most obesity drugs primarily work by reducing metabolizable energy intake, elucidation of the time course of energy intake changes during long-term obesity pharmacotherapy has been prevented by the limitations of self-report methods of measuring energy intake. METHODS A validated mathematical model of human metabolism was used to provide the first quantificatio...
متن کامل